Paul has over 20 years’ experience advising companies in the healthcare industry at all stages of development from start-up to pre-IPO to mature listed businesses.
He is currently General Counsel, Head of Strategic Affairs & Company Secretary at BTG plc, a FTSE250 healthcare company providing a range of innovative medical devices and specialty pharmaceuticals. At BTG Paul is a member of the executive Leadership Team managing the Legal, Regulatory, Intellectual Property, Healthcare Compliance and Risk Management functions.
He has extensive experience of supporting the establishment of corporate governance & risk management frameworks; Corporate Finance; Mergers & Acquisitions (private & public); fundraisings and investment (equity, private equity & debt); IP licensing & business development; supporting drug and medical device research, development, manufacturing & commercialization; complex litigation and dispute resolution.
Paul has a BSc(Hons) in Biotechnology and a Ph.D in molecular biology and microbial physiology. Having qualified as a solicitor with Norton Rose Fulbright before joining BTG, Paul focused for a number of years in the area of corporate finance and corporate development before moving to the Equity Markets Group of the London Stock Exchange focusing on healthcare company transactions.Back to our trustees